Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Global Blood Therapeutics, Inc. (GBT)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21Dec-31-20Sep-30-20
   10-Q10-Q8-K8-K10-Q10-Q10-K10-Q
Total revenues   [+]344.4320.4304.2230.5164.8148.7123.884.6
            Revenue growth  109.0%115.4%145.7%172.4%216.3%511.9%783.2%305.4%
Cost of goods sold  55.054.353.853.72.82.42.01.1
Gross profit  289.4266.0250.4176.8162.0146.3121.883.5
            Gross margin  84.0%83.0%82.3%76.7%98.3%98.4%98.4%98.7%
Selling, general and administrative   [+]302.6282.6267.0247.7234.2222.2210.9195.8
Research and development  117.6104.6  183.9166.2155.1179.0
Other operating expenses    168.549.5  -1.0 
EBITDA   [+]-296.2-286.6  -249.5-233.6-234.9-273.8
            EBITDA margin  -86.0%-89.4%-93.6%-112.7%-151.4%-157.1%-189.7%-323.6%
Depreciation and amortization  3.13.0  5.77.58.39.2
EBIT   [+]-299.2-289.6-287.7-264.1-255.1-241.1-243.2-283.0
            EBIT margin  -86.9%-90.4%-94.6%-114.6%-154.8%-162.1%-196.4%-334.5%
Interest expense    4.3     
Other income (expense), net   [+]-18.6-15.5-11.0-13.1-10.9-8.2-4.4-2.0
Pre-tax income  -322.1-309.4-302.9-277.2-266.1-249.3-247.6-281.7
Income taxes  0.40.20.20.20.20.10.00.0
            Tax rate    -0.1%-0.1%  0.0%0.0%
Net income  -322.5-309.6-303.1-277.3-266.2-249.5-247.6-281.7
            Net margin  -93.6%-96.6%-99.6%-120.3%-161.6%-167.7%-200.0%-332.9%
   
Basic EPS   [+]($5.00)($4.86)($4.81)($4.46)($4.31)($4.04)($4.03)($4.64)
Diluted EPS   [+]($5.00)($4.86)($4.81)($4.46)($4.31)($4.04)($4.03)($4.64)
   
Shares outstanding (basic)   [+]64.563.663.062.261.861.861.560.7
Shares outstanding (diluted)   [+]64.563.663.062.261.861.861.560.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy